# ACCO BRANDS Corp: financial statements, quarterly ACCO · NYSE · CIK 712034 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/acco.md) · [Financials](/companies/acco/financials.md) · [Filings](/companies/acco/filings.md) · [Insiders](/companies/acco/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/acco/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [448](/filings/0000950170-24-119895.md) | [489 d](/filings/0001193125-26-098616.md) | [359](/filings/0000950170-25-062490.md) | [438](/filings/0000950170-25-101292.md) | [421](/filings/0001193125-25-260601.md) | [448 d](/filings/0001193125-26-098616.md) | [317](/filings/0001193125-26-201006.md) | [395](/filings/0001193125-26-328057.md) | [384](/filings/0001193125-25-260601.md) | [429 d](/filings/0001193125-26-098616.md) | [344](/filings/0001193125-26-201006.md) | [415](/filings/0001193125-26-328057.md) | | Cost of revenue | $m | [303](/filings/0000950170-24-119895.md) | [319 d](/filings/0001193125-26-098616.md) | [249](/filings/0000950170-25-062490.md) | [286](/filings/0000950170-25-101292.md) | [284](/filings/0001193125-25-260601.md) | [293 d](/filings/0001193125-26-098616.md) | [218](/filings/0001193125-26-201006.md) | [265](/filings/0001193125-26-328057.md) | [257](/filings/0001193125-25-260601.md) | [285 d](/filings/0001193125-26-098616.md) | [237](/filings/0001193125-26-201006.md) | [281](/filings/0001193125-26-328057.md) | | Gross profit | $m | [145](/filings/0000950170-24-119895.md) | [170 d](/filings/0001193125-26-098616.md) | [110](/filings/0000950170-25-062490.md) | [153](/filings/0000950170-25-101292.md) | [137](/filings/0001193125-25-260601.md) | [156 d](/filings/0001193125-26-098616.md) | [99.6](/filings/0001193125-26-201006.md) | [130](/filings/0001193125-26-328057.md) | [127](/filings/0001193125-25-260601.md) | [144 d](/filings/0001193125-26-098616.md) | [107](/filings/0001193125-26-201006.md) | [134](/filings/0001193125-26-328057.md) | | Selling, general and administrative | $m | [98.8](/filings/0000950170-24-119895.md) | [102 d](/filings/0001193125-26-098616.md) | [94.2](/filings/0000950170-25-062490.md) | [88.0](/filings/0000950170-25-101292.md) | [92.2](/filings/0001193125-25-260601.md) | [91.3 d](/filings/0001193125-26-098616.md) | [92.7](/filings/0001193125-26-201006.md) | [82.6](/filings/0001193125-26-328057.md) | [87.4](/filings/0001193125-25-260601.md) | [84.0 d](/filings/0001193125-26-098616.md) | [99.1](/filings/0001193125-26-201006.md) | [91.2](/filings/0001193125-26-328057.md) | | Operating income | $m | [32.2](/filings/0000950170-24-119895.md) | [(52.8) d](/filings/0001193125-26-098616.md) | [5.9](/filings/0000950170-25-062490.md) | [(111)](/filings/0000950170-25-101292.md) | [26.3](/filings/0001193125-25-260601.md) | [42.0 d](/filings/0001193125-26-098616.md) | [(6.7)](/filings/0001193125-26-201006.md) | [33.0](/filings/0001193125-26-328057.md) | [26.0](/filings/0001193125-25-260601.md) | [40.0 d](/filings/0001193125-26-098616.md) | [(10.4)](/filings/0001193125-26-201006.md) | [30.3](/filings/0001193125-26-328057.md) | | Interest expense | $m | [15.6](/filings/0000950170-24-119895.md) | [13.6 d](/filings/0001193125-26-098616.md) | [13.3](/filings/0000950170-25-062490.md) | [13.8](/filings/0000950170-25-101292.md) | [13.7](/filings/0001193125-25-260601.md) | [11.8 d](/filings/0001193125-26-098616.md) | [10.8](/filings/0001193125-26-201006.md) | [11.9](/filings/0001193125-26-328057.md) | [12.5](/filings/0001193125-25-260601.md) | [10.6 d](/filings/0001193125-26-098616.md) | [10.8](/filings/0001193125-26-201006.md) | [12.0](/filings/0001193125-26-328057.md) | | Income tax | $m | [6.7](/filings/0000950170-24-119895.md) | [(14.0) d](/filings/0001193125-26-098616.md) | [1.0](/filings/0000950170-25-062490.md) | [(2.2)](/filings/0000950170-25-101292.md) | [4.5](/filings/0001193125-25-260601.md) | [11.0 d](/filings/0001193125-26-098616.md) | [(3.3)](/filings/0001193125-26-201006.md) | [(6.5)](/filings/0001193125-26-328057.md) | [10.7](/filings/0001193125-25-260601.md) | [6.9 d](/filings/0001193125-26-098616.md) | [(4.5)](/filings/0001193125-26-201006.md) | [5.6](/filings/0001193125-26-328057.md) | | Net income | $m | [14.9](/filings/0000950170-24-119895.md) | [(59.4) d](/filings/0001193125-26-098616.md) | [(6.3)](/filings/0001193125-25-260601.md) | [(125)](/filings/0001193125-25-260601.md) | [9.3](/filings/0001193125-25-260601.md) | [20.6 d](/filings/0001193125-26-098616.md) | [(13.2)](/filings/0001193125-26-328057.md) | [29.2](/filings/0001193125-26-328057.md) | [4.0](/filings/0001193125-25-260601.md) | [21.3 d](/filings/0001193125-26-098616.md) | [19.4](/filings/0001193125-26-328057.md) | [14.1](/filings/0001193125-26-328057.md) | | Diluted EPS | $ per share | [0.15](/filings/0000950170-24-119895.md) | not reported | [(0.07)](/filings/0000950170-25-062490.md) | [(1.29)](/filings/0000950170-25-101292.md) | [0.09](/filings/0001193125-25-260601.md) | not reported | [(0.14)](/filings/0001193125-26-201006.md) | [0.31](/filings/0001193125-26-328057.md) | [0.04](/filings/0001193125-25-260601.md) | not reported | [0.20](/filings/0001193125-26-201006.md) | [0.15](/filings/0001193125-26-328057.md) | | Basic EPS | $ per share | [0.16](/filings/0000950170-24-119895.md) | not reported | [(0.07)](/filings/0000950170-25-062490.md) | [(1.29)](/filings/0000950170-25-101292.md) | [0.10](/filings/0001193125-25-260601.md) | not reported | [(0.14)](/filings/0001193125-26-201006.md) | [0.32](/filings/0001193125-26-328057.md) | [0.04](/filings/0001193125-25-260601.md) | not reported | [0.21](/filings/0001193125-26-201006.md) | [0.15](/filings/0001193125-26-328057.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current assets | $m | [835](/filings/0000950170-23-058591.md) | [855](/filings/0000950170-25-024931.md) | [798](/filings/0000950170-24-052651.md) | [858](/filings/0000950170-24-089733.md) | [794](/filings/0000950170-24-119895.md) | [732](/filings/0001193125-26-098616.md) | [743](/filings/0000950170-25-062490.md) | [836](/filings/0000950170-25-101292.md) | [733](/filings/0001193125-25-260601.md) | [750](/filings/0001193125-26-328057.md) | [798](/filings/0001193125-26-201006.md) | [859](/filings/0001193125-26-328057.md) | | Total assets | $m | [2,684](/filings/0000950170-23-058591.md) | [2,645](/filings/0000950170-25-024931.md) | [2,544](/filings/0000950170-24-052651.md) | [2,413](/filings/0000950170-24-089733.md) | [2,358](/filings/0000950170-24-119895.md) | [2,228](/filings/0001193125-26-098616.md) | [2,269](/filings/0000950170-25-062490.md) | [2,378](/filings/0000950170-25-101292.md) | [2,259](/filings/0001193125-25-260601.md) | [2,253](/filings/0001193125-26-328057.md) | [2,282](/filings/0001193125-26-201006.md) | [2,324](/filings/0001193125-26-328057.md) | | Current liabilities | $m | [519](/filings/0000950170-23-058591.md) | [542](/filings/0000950170-25-024931.md) | [473](/filings/0000950170-24-052651.md) | [484](/filings/0000950170-24-089733.md) | [498](/filings/0000950170-24-119895.md) | [490](/filings/0001193125-26-098616.md) | [421](/filings/0000950170-25-062490.md) | [453](/filings/0000950170-25-101292.md) | [437](/filings/0001193125-25-260601.md) | [465](/filings/0001193125-26-328057.md) | [450](/filings/0001193125-26-201006.md) | [435](/filings/0001193125-26-328057.md) | | Total liabilities | $m | [1,846](/filings/0000950170-23-058591.md) | [1,858](/filings/0000950170-25-024931.md) | [1,785](/filings/0000950170-24-052651.md) | [1,796](/filings/0000950170-24-089733.md) | [1,742](/filings/0000950170-24-119895.md) | [1,622](/filings/0001193125-26-098616.md) | [1,663](/filings/0000950170-25-062490.md) | [1,740](/filings/0000950170-25-101292.md) | [1,615](/filings/0001193125-25-260601.md) | [1,588](/filings/0001193125-26-328057.md) | [1,602](/filings/0001193125-26-201006.md) | [1,633](/filings/0001193125-26-328057.md) | | Long-term debt | $m | [892](/filings/0000950170-23-058591.md) | [882](/filings/0000950170-25-024931.md) | [898](/filings/0000950170-24-052651.md) | [918](/filings/0000950170-24-089733.md) | [850](/filings/0000950170-24-119895.md) | [783](/filings/0001193125-26-098616.md) | [898](/filings/0000950170-25-062490.md) | [944](/filings/0000950170-25-101292.md) | [838](/filings/0001193125-25-260601.md) | [806](/filings/0001193125-26-328057.md) | [848](/filings/0001193125-26-201006.md) | [897](/filings/0001193125-26-328057.md) | | Current portion of debt | $m | [67.2](/filings/0000950170-23-058591.md) | [36.5](/filings/0000950170-25-024931.md) | [57.3](/filings/0000950170-24-052651.md) | [48.3](/filings/0000950170-24-089733.md) | [51.3](/filings/0000950170-24-119895.md) | [40.8](/filings/0001193125-26-098616.md) | [25.2](/filings/0000950170-25-062490.md) | [19.4](/filings/0000950170-25-101292.md) | [25.2](/filings/0001193125-25-260601.md) | [30.8](/filings/0001193125-26-328057.md) | [25.7](/filings/0001193125-26-201006.md) | [21.6](/filings/0001193125-26-328057.md) | | Shareholders' equity | $m | [838](/filings/0000950170-24-119895.md) | [787](/filings/0001193125-26-098616.md) | [759](/filings/0001193125-25-260601.md) | [617](/filings/0001193125-25-260601.md) | [616](/filings/0001193125-25-260601.md) | [606](/filings/0001193125-26-328057.md) | [606](/filings/0001193125-26-328057.md) | [637](/filings/0001193125-26-328057.md) | [644](/filings/0001193125-25-260601.md) | [665](/filings/0001193125-26-328057.md) | [680](/filings/0001193125-26-328057.md) | [691](/filings/0001193125-26-328057.md) | - Cash and equivalents: not reported - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [110 d](/filings/0000950170-24-119895.md) | [58.0 d](/filings/0001193125-26-098616.md) | [28.2](/filings/0000950170-25-062490.md) | [(25.6) d](/filings/0000950170-25-101292.md) | [92.9 d](/filings/0001193125-25-260601.md) | [52.7 d](/filings/0001193125-26-098616.md) | [5.5](/filings/0001193125-26-201006.md) | [(38.9) d](/filings/0001193125-26-328057.md) | [71.5 d](/filings/0001193125-25-260601.md) | [30.6 d](/filings/0001193125-26-098616.md) | [3.5](/filings/0001193125-26-201006.md) | [(35.3) d](/filings/0001193125-26-328057.md) | | Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Dividends paid | $m | [7.2 d](/filings/0000950170-24-119895.md) | [7.1 d](/filings/0001193125-26-098616.md) | [7.2](/filings/0000950170-25-062490.md) | [7.1 d](/filings/0000950170-25-101292.md) | [7.2 d](/filings/0001193125-25-260601.md) | [6.9 d](/filings/0001193125-26-098616.md) | [6.8](/filings/0001193125-26-201006.md) | [6.7 d](/filings/0001193125-26-328057.md) | [6.8 d](/filings/0001193125-25-260601.md) | [6.7 d](/filings/0001193125-26-098616.md) | [6.9](/filings/0001193125-26-201006.md) | [6.9 d](/filings/0001193125-26-328057.md) | | Share repurchases | $m | [0.0 d](/filings/0000950170-23-058591.md) | [0.0 d](/filings/0001193125-26-098616.md) | [0.0](/filings/0000950170-25-062490.md) | [0.0 d](/filings/0000950170-25-101292.md) | [12.5 d](/filings/0001193125-25-260601.md) | [2.5 d](/filings/0001193125-26-098616.md) | [15.0](/filings/0001193125-26-201006.md) | [0.1 d](/filings/0001193125-26-328057.md) | [0.0 d](/filings/0001193125-25-260601.md) | [0.0 d](/filings/0001193125-26-098616.md) | [0.0](/filings/0001193125-26-201006.md) | [0.0 d](/filings/0001193125-26-328057.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: not reported - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [94.5](/filings/0000950170-23-058591.md) | [94.9](/filings/0000950170-24-052651.md) | [96.3](/filings/0000950170-24-089733.md) | [96.7](/filings/0000950170-24-119895.md) | [95.7](/filings/0000950170-25-062490.md) | [96.8](/filings/0000950170-25-101292.md) | [97.5](/filings/0001193125-25-260601.md) | [93.3](/filings/0001193125-26-201006.md) | [93.1](/filings/0001193125-26-328057.md) | [93.3](/filings/0001193125-25-260601.md) | [95.5](/filings/0001193125-26-201006.md) | [95.6](/filings/0001193125-26-328057.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 92,307,568 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001193125-26-328057.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.